The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 229.00
Bid: 228.00
Ask: 230.00
Change: -2.00 (-0.87%)
Spread: 2.00 (0.877%)
Open: 231.00
High: 234.00
Low: 229.00
Prev. Close: 231.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

14 Jun 2022 07:00

RNS Number : 7203O
Spectra Systems Corporation
14 June 2022
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Chief Financial Officer

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software is delighted to announce that it has agreed to appoint Colleen Hamill, C.P.A. (aged 56) as its new Chief Financial Officer.

Colleen Hamill started her career in 1987 at KPMG Peat Marwick in public accounting prior to working as an Accounting Manager at HMK Enterprises, Inc. an $820MM diversified holding company from 1990 to 1996. From 1996 to 2007, Ms. Hamill was the Global Corporate Controller and a member of the senior management at Brewster Wallcovering, a global distributer and manufacturer of wall covering and related products. Following this position, she held the position of Senior Director of Corporate Accounting at GTECH (now IGT) for eight months before moving to the position of Senior Manager for Financial Reporting at Brookfield Renewable Power, a $12B operator and developer of hydroelectric power facilities. From 2010 to 2015, Ms. Hamill was the Global Manager for consolidations at Covidien, a $10B medical devices company. From this position, she has worked as the Finance Leader in the US operations of Boston-Power, a venture capital-backed developer and manufacturer of lithium-ion batteries and most recently as the Global Controller at Harvard Biosciences.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Colleen Hamill has confirmed that there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

 

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Colleen to Spectra Systems and believe that her extensive financial experience, particularly in technology driven companies will be of immense value to us."

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Broker)

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

Tel: +44 (0)20 3328 5665

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFMFADEESEFM
Date   Source Headline
19th Mar 20187:00 amRNSPreliminary Results
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20187:00 amRNSTrading Update
15th Jan 20187:00 amRNSLicensing Agreement and Supply Agreement
11th Dec 20177:00 amRNSAnnual General Meeting Postponed
10th Nov 20174:32 pmRNSHolding(s) in Company
23rd Oct 20173:44 pmRNSExercise of Options
16th Oct 20177:00 amRNSTrading Update
5th Oct 20177:00 amRNSNew Opportunity in Consumer Products
14th Sep 20175:34 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSTrading Update and Interim Results Date
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
26th Jun 20177:00 amRNSIssuance of Patents
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSIssuance of Patents
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.